Clinical UpdatesDrug News

A new study of the multiple sclerosis drug Tysabri shows some patients developed the virus associated with a potentially deadly… »   

A deadlocked U.S. Supreme Court upheld a lower court decision against Pfizer Inc’s Warner-Lambert unit over withdrawn diabetes drug Rezulin… »   

Merck & Co Monday said more than 93 percent of the 47,000 people who allege the arthritis drug Vioxx caused… »   

Researchers have long searched for a novel cancer drug that activates a certain protein to kill tumor cells. But finding… »   

GlaxoSmithKline Plc’s new breast cancer drug Tykerb is to go head-to-head with Genentech Inc’s blockbuster Herceptin to see whether one… »   

The identification of two cellular receptors that likely contribute to the genesis of hormone-dependent breast cancer points the way to… »   

Medical device companies will come under scrutiny on Wednesday when a U.S. Senate committee probes financial payments to doctors, which… »   

AstraZeneca Plc is stopping a clinical trial of Recentin as a treatment for lung cancer after a mid-stage study failed… »   

In an article published in the March issue of the Journal of Cardiovascular Pharmacology and Therapeutics, researchers from Florida Atlantic… »   

An experimental, combination vaccine against Ebola and Marburg viruses using virus-like particles (VLPs) provides complete protection against infection in monkeys.… »   

Wellcome Trust Sanger Institute scientists have developed a new large-scale method to identify the interactions between proteins that are a… »   

The United States and European Union are in talks to resolve their dispute over the EU’s ban on genetically modified… »   

A small number of flu viruses resistant to Tamiflu, a top antiviral drug, have been detected in Europe, health authorities… »   

Doctors in England are writing over a million obesity drug prescriptions a year, eight times more than in 1999, health… »   

Weeks before a damaging report on the diabetes drug Avandia (rosiglitazone) was to appear in The New England Journal of… »